GEA Pharma & Healthcare share company updates at CPHI Barcelona

Published: 25-Jan-2024 Featured companies: GEA Pharma and Healthcare
Media

Jim Holman, Technology Management Senior Director at GEA Pharma & Healthcare, discusses the company's recent endeavours to enhance the sustainability of their manufacturing procedures, the development of their novel tablet press range and the digital Canary system

GEA Pharma & Healthcare are key players in pharmaceutical production. 

 

 

Jim elaborates on a range of company developments, including the launch of the NexGen 30 tablet press and why it is unique in the market, development of their sustainability initiatives and the Digital Canary system UC, D and C.

To finish, he talks through what can be expected in 2024 from GEA.

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

 

Featured companies

GEA is a leading provider of process technology and packaging solutions for the pharmaceutical, biopharmaceutical, biotechnology and nutraceutical industries. Our portfolio...
See more

You may also like

Media

BioPharma Dynamics proudly sponsor GMCC Excellence Awards

Read more
BioPharma Dynamics is proud to continue their headline sponsorship of Greater Manchester Chamber of Commerce Excellence Awards, championing success and achievements of businesses within the Greater Manchester region

Trending Articles

  1. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  2. New-age technology drives targeted drug delivery North America is home to the majority of drug delivery innovations, says Frost & Sullivan
  3. Johnson Matthey buys Davy Process Technology Johnson Matthey has purchased developer of chemical process technologies, Davy Process Technology (DPT), from Yukos International UK for
  4. Global dermatology market set to reach US$33.7bn by 2022, despite patent expiries Growth will be driven by a strong late-stage pipeline, which includes several highly valuable targeted therapies
  5. Accord Healthcare opens new UK factory to increase EU presence New site to be EMENA centre for excellence and create more than 500 jobs

Relevant companies

See more

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Media

BioPharma Dynamics proudly sponsor GMCC Excellence Awards

BioPharma Dynamics is proud to continue their headline sponsorship of Greater Manchester Chamber of Commerce Excellence Awards, championing success and achievements of businesses within the Greater Manchester region
Media

Chemspec Europe 2024 conference programme unveiled

A detailed look at key speakers, sessions, and networking opportunities at the international exhibition
Media

Curia receives 2024 CDMO leadership award

Curia recognised for its service in the CDMO industry
Media

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN

Biovian and 3P Biopharmaceuticals, two leading biologics CDMOs, announce their combination to establish a new pan-European leader in their field
Media

Royal Society of Chemistry and TIB co-create next generation Open Access consortium model

The agreement delivers shared goals of equity for institutions, a community approach and universal open access for authors
Media

Thermo Fisher launches industry’s first off-the-shelf solution to streamline and automate cell therapy manufacturing

Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing
Media

Two new appointed members have joined the RSC’s Board of Trustees

The dual appointment will add invaluable commercial acumen and project leadership experience
Subscribe now